Mayne Pharma expands manufacturing capacity with $4.8M grant

Mayne Pharma will receive up to $4.8 million to expand its advanced manufacturing capability, aiming to double production of chronic pain medications, boost encapsulation capacity from 56 million to 104 million doses per year, and increase blister packaging capacity from 7.9 million to 21.3 million boxes per year.

“This funding is a big win for jobs and another vote of confidence in South Australia’s advanced manufacturing capability.”bulkhandlingreview.com.au

• 1 source
• bulkhandlingreview.com.auFederal funding for concrete and glass manufacturing - Australian Bulk Handling ReviewWilliam ArnottMay 11, 2022

Summarized from public sources; check the original articles before acting on it.